State Street’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,677,893
| Closed | -$184M | – | 4714 |
|
|
2023
Q2 | $184M | Sell |
4,677,893
-946,285
| -17% | -$33.4M | 0.01% | 841 |
|
|
2023
Q1 | $137M | Sell |
5,624,178
-712,658
| -11% | -$15.6M | 0.01% | 996 |
|
|
2022
Q4 | $136M | Buy |
6,336,836
+92,480
| +1% | +$1.97M | 0.01% | 976 |
|
|
2022
Q3 | $112M | Sell |
6,244,356
-2,489,234
| -29% | -$32.7M | 0.01% | 1043 |
|
|
2022
Q2 | $84M | Buy |
8,733,590
+2,843,747
| +48% | +$35.7M | 0.01% | 1293 |
|
|
2022
Q1 | $99.1M | Buy |
5,889,843
+104,692
| +2% | +$1.55M | ﹤0.01% | 1306 |
|
|
2021
Q4 | $96.7M | Buy |
5,785,151
+1,045,693
| +22% | +$17.1M | ﹤0.01% | 1326 |
|
|
2021
Q3 | $77M | Buy |
4,739,458
+1,533,832
| +48% | +$16.7M | ﹤0.01% | 1477 |
|
|
2021
Q2 | $20.2M | Sell |
3,205,626
-489,357
| -13% | -$3.16M | ﹤0.01% | 2500 |
|
|
2021
Q1 | $22.8M | Buy |
3,694,983
+279,711
| +8% | +$1.7M | ﹤0.01% | 2289 |
|
|
2020
Q4 | $23.6M | Buy |
3,415,272
+2,249,858
| +193% | +$14.4M | ﹤0.01% | 2142 |
|
|
2020
Q3 | $6.57M | Buy |
1,165,414
+424,379
| +57% | +$2.02M | ﹤0.01% | 2657 |
|
|
2020
Q2 | $3.78M | Buy |
+741,035
| New | +$3.09M | ﹤0.01% | 2906 |
|
|
2019
Q4 | – | Sell |
-41,652
| Closed | -$47K | – | 3835 |
|
|
2019
Q3 | $47K | Hold |
41,652
| – | – | ﹤0.01% | 3726 |
|
|
2019
Q2 | $54K | Hold |
41,652
| – | – | ﹤0.01% | 3714 |
|
|
2019
Q1 | $59K | Hold |
41,652
| – | – | ﹤0.01% | 3670 |
|
|
2018
Q4 | $50K | Hold |
41,652
| – | – | ﹤0.01% | 3679 |
|
|
2018
Q3 | $99K | Sell |
41,652
-2,893
| -6% | -$7.21K | ﹤0.01% | 3654 |
|
|
2018
Q2 | $121K | Sell |
44,545
-15,826
| -26% | -$43.7K | ﹤0.01% | 3613 |
|
|
2018
Q1 | $166K | Buy |
60,371
+4,686
| +8% | +$13.6K | ﹤0.01% | 3573 |
|
|
2017
Q4 | $174K | Buy |
55,685
+9,685
| +21% | +$27.2K | ﹤0.01% | 3579 |
|
|
2017
Q3 | $129K | Sell |
46,000
-11,900
| -21% | -$32.1K | ﹤0.01% | 3626 |
|
|
2017
Q2 | $149K | Sell |
57,900
-536,215
| -90% | -$1.46M | ﹤0.01% | 3544 |
|
|
2017
Q1 | $2.17M | Sell |
594,115
-962,077
| -62% | -$4.07M | ﹤0.01% | 3056 |
|
|
2016
Q4 | $7.51M | Buy |
1,556,192
+421,671
| +37% | +$12.5M | ﹤0.01% | 2471 |
|
|
2016
Q3 | $52.3M | Buy |
1,134,521
+272,974
| +32% | +$15.4M | 0.01% | 1198 |
|
|
2016
Q2 | $44M | Sell |
861,547
-217,290
| -20% | -$10.8M | ﹤0.01% | 1252 |
|
|
2016
Q1 | $45.6M | Buy |
1,078,837
+371,894
| +53% | +$18.9M | ﹤0.01% | 1213 |
|
|
2015
Q4 | $55.5M | Sell |
706,943
-158,063
| -18% | -$9.14M | 0.01% | 1126 |
|
|
2015
Q3 | $35.1M | Buy |
865,006
+21,969
| +3% | +$1.16M | ﹤0.01% | 1368 |
|
|
2015
Q2 | $43.9M | Buy |
843,037
+218,127
| +35% | +$10.9M | ﹤0.01% | 1351 |
|
|
2015
Q1 | $29.1M | Buy |
624,910
+74,068
| +13% | +$3.85M | ﹤0.01% | 1575 |
|
|
2014
Q4 | $24.7M | Sell |
550,842
-36,401
| -6% | -$1.53M | ﹤0.01% | 1652 |
|
|
2014
Q3 | $22.9M | Buy |
587,243
+84,150
| +17% | +$3.3M | ﹤0.01% | 1643 |
|
|
2014
Q2 | $21.3M | Buy |
503,093
+371,872
| +283% | +$13.6M | ﹤0.01% | 1778 |
|
|
2014
Q1 | $4.69M | Buy |
131,221
+962
| +0.7% | +$32.5K | ﹤0.01% | 2599 |
|
|
2013
Q4 | $4.21M | Buy |
+130,259
| New | +$3.86M | ﹤0.01% | 2673 |
|
State Street's ISEE Position: Q3 2023 in Review
State Street sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 4,677,893 shares — an estimated $184M sold.
State Street first reported a position in ISEE in Q4 2013 and held it in 37 quarters. The position peaked at $184M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- State Street reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- State Street sold 4,677,893 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $184M.
- State Street first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 37 quarters.
- State Street's IVERIC bio, Inc. Common Stock position peaked at $184M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.